Lanzamiento Enero 2027

Ensayo controlado aleatorizado1997Financiación no declarada

Effect of increasing breast milk docosahexaenoic acid on plasma and erythrocyte phospholipid fatty acids and neural indices of exclusively breast fed infants

Gibson RA, Neumann MA, Makrides M

European journal of clinical nutrition · 159 citas

Etiquetas de revisión

Financiación no declarada

Datos neutrales que nuestra revisión registró sobre cómo se hizo este estudio. Describen el método, nunca si nos gusta el resultado.

Cómo se estudió

Diseño
Ensayo controlado aleatorizado (indexado por PubMed)
Estudiado en
Personas
Resultado principal
Marcadores de salud y funcionamiento

Quién lo pagó

Financiación
Financiación no declarada

Publicación

Publicado
1997-09-01 · Eur J Clin Nutr · vol. 51 · número 9 · págs. 578–584
Editorial
Springer Nature
Citado
253 citas · más que el 98% de estudios similares · 7.1× el promedio de su campo
Impacto
Entre el 10 % más citado de su campo
Referencias
17 trabajos
Acceso
De pago
Áreas de investigación
Fatty Acid Research and Health · Infant Nutrition and Health · Breastfeeding Practices and Influences
Palabras clave
docosahexaenoic acid, breast milk, maternal supplementation, erythrocyte phospholipids, omega-6 fatty acids, visual evoked potentials, infant brain development, Bayley Scales of Infant Development, home stimulation, term infants
MeSH
nervous system, erythrocytes, milk, human, humans, docosahexaenoic acids, fatty acids, fatty acids, unsaturated, fatty acids, omega-6, phospholipids, diet, regression analysis, mental processes, psychomotor performance, breast feeding, evoked potentials, visual, infant, female

3 autores

  • Robert Alan Gibson🇦🇺Flinders Medical Centre
  • MA Neumann🇦🇺Flinders Medical Centre
  • M Makrides🇦🇺Flinders University

Resumen

El texto original del estudio, en el idioma en que se publicó.

Objectives

To determine the effect of increasing docosahexaenoic acid (DHA, 22:6 n-3) in breast milk on infant fatty acid profiles. A secondary aim was to examine aspects of neural development.

Design and setting

Double blind, placebo controlled study of infants recruited from postnatal wards at Flinders Medical Centre.

Subjects

Fifty-two healthy term infants who were breast fed for at least 12 weeks and were from middle class families.

Intervention

Breast milk with DHA concentrations that ranged from 0.1-1.7% of total fatty acids. This was achieved by supplementation of the maternal diet for the first 12 weeks post partum.

Results

Breast milk with DHA was related to infant plasma (r = 0.89, P < 0.001) and erythrocyte (r = 88, P < 0.001) phospholipids in a saturable curvilinear manner so that breast milk DHA above 0.8% of total fatty acids resulted in little further increase in infant plasma or erythrocyte DHA levels. The rise in plasma and erythrocyte DHA was approximated by a fall in total n-6 polyunsaturated fatty acids. We could detect no relationship between visual evoked potential acuity (measured at 12 and 16 weeks) of infants by either the dietary grouping or the DHA status of individuals. A stepwise multiple regression showed that infant erythrocyte DHA at 12 weeks and home stimulation were the only independent factors associated with Bayley's MDI at 1 y (adjusted model r2 = 0.18, P < 0.005); while at 2 y gender and social score of the spouse were the only significant predictors of Bayley's MDI (adjusted model r2 = 0.22, P < 0.005).

Conclusions

Increasing breast milk DHA levels caused a dose dependent saturable increase in infant plasma and erythrocyte phospholipid DHA. There were no long-term effects of infant DHA status on indices of neurodevelopment.

Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.

Confianza de la comunidad

Cargando…

¿Cuánto confías en los hallazgos de este estudio?

0 · nada10 · totalmente

Comentarios

¿Algo está mal aquí?

Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.

Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.